Active Ingredient: RANOLAZINE
Proprietary Name: RANOLAZINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A210482
Product Number: 001
Approval Date: Oct 29, 2019
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information